|
MES-SA
|
31.6 nM
|
PrestoBlue viability reagent, Sigmoidal curve fitting
|
Download PDF
|
|
MES-SA/Dx5
|
3.16 µM
|
PrestoBlue viability reagent, Sigmoidal curve fitting
|
Download PDF
|
|
HeLa cell line
|
1.0±0.2 μM
|
crystal violet assay
|
PMC6235738
|
|
MCF-7
|
2.10 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12919367
|
|
MCF-7
|
1.45 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
PMC12919367
|
|
C1498 cells
|
0.32 g/ml
|
in vitro cytotoxicity assay
|
PMC7725453
|
|
HT1080
|
0.1 μM
|
resazurin-based cytotoxicity assay
|
PMC6307086
|
|
B16F10-Luc
|
0.1 µg/ml
|
Dose-response curve analysis for cell killing efficacy
|
PMC6853768
|
|
OVCAR8
|
2.1 μM
|
MTT assay
|
PMC4046789
|
|
OVCAR8
|
1.5 μM
|
MTT assay
|
PMC4046789
|
|
OVCAR8/ADR
|
150 μM
|
MTT assay
|
PMC4046789
|
|
OVCAR8/ADR
|
99.8 μM
|
MTT assay
|
PMC4046789
|
|
GL261 cells
|
0.8 ± 0.05 lg/mL
|
MTT assay
|
PMC8655135
|
|
CT26 cells
|
3 mM
|
Cell Counting Kit-8
|
PMC5906077
|
|
MC38 cells
|
0.11 mM
|
Cell Counting Kit-8
|
PMC5906077
|
|
4T1 cells
|
16 µg/mL
|
CCK-8 kit
|
PMC12964734
|
|
B16F10 cells
|
7.049 µM
|
MTT assay
|
PMC12164105
|
|
PANC-1 cells
|
4.651 µM
|
CCK-8 assay
|
PMC11657701
|
|
4T1 cells
|
7.7 µg/mL
|
CCK-8 assay
|
PMC11786351
|
|
B16F10 cells
|
0.339 μM
|
CCK8 assay
|
PMC11337894
|
|
4T1 cells
|
16.585 ± 3.68 µg/mL
|
CCK-8 test
|
PMC12853939
|
|
4T1 cells
|
2.14 µM
|
MTS assay
|
Download PDF
|
|
MDAMB-231
|
22 µM
|
MTT assay
|
Download PDF
|
|
4T1
|
16 µM
|
MTT assay
|
Download PDF
|
|
MDAMB-231
|
8 µM
|
MTT assay
|
Download PDF
|
|
4T1
|
7 µM
|
MTT assay
|
Download PDF
|
|
MCF-10A
|
6.9 µM
|
MTT assay
|
Download PDF
|
|
HT29
|
2.8 µM
|
MTT assay
|
Download PDF
|
|
4T1 cells
|
1.25 µg/mL
|
Cytotoxicity assay
|
Download PDF
|
|
ARO
|
1.6 nM
|
colorimetric MTT assay
|
Download PDF
|
|
Tca8113
|
2.2 nM
|
colorimetric MTT assay
|
Download PDF
|
|
4T1-SP
|
870 nM
|
Cytotoxicity assay (implied)
|
Download PDF
|
|
4T1
|
80.47 nM
|
Cytotoxicity assay (implied)
|
Download PDF
|
|
4T1/DOX
|
578.4 nM
|
Cytotoxicity assay (implied)
|
Download PDF
|
|
MCF-7
|
0.08 µg/mL
|
CCK-8 kit
|
Download PDF
|
|
K562
|
0.15 µg/mL
|
CCK-8 kit
|
Download PDF
|
|
MCF-7/ADR
|
72.12 μg/mL
|
CCK-8 kit
|
Download PDF
|
|
K562/ADR
|
18.91 μg/mL
|
CCK-8 kit
|
Download PDF
|
|
BCPAP cells
|
1.72 μM
|
MTT assay
|
Download PDF
|
|
HeLa cells
|
>40 µM
|
Cell Counting Kit-8 assay
|
Download PDF
|
|
DT40 cells
|
1.69 nM
|
clonogenic survival assay
|
Download PDF
|
|
MCF-7
|
0.09 μg/mL
|
Cell viability assay (e.g., CCK-8)
|
Download PDF
|
|
MCF-7/ADR
|
9.72 μg/mL
|
Cell viability assay (e.g., CCK-8)
|
Download PDF
|
|
MDA-MB-231
|
158 nM
|
MTT assay
|
Download PDF
|
|
MDA-MB-231 HER2 OE
|
346 nM
|
MTT assay
|
Download PDF
|
|
SK-BR-3
|
144 nM
|
MTT assay
|
Download PDF
|
|
SK-BR-3 KO
|
147 nM
|
MTT assay
|
Download PDF
|
|
B16F10 mice melanoma cells
|
335.81 nM
|
Alamarblue assay
|
Download PDF
|
|
HCT 116 cells
|
1.6 µM
|
MTS test
|
Download PDF
|
|
HEL
|
0.345 ± 0.0352 µM
|
Cell viability assay
|
Download PDF
|
|
OCI-AML3
|
1.31 ± 0.00503 µM
|
Cell viability assay
|
Download PDF
|
|
captured & released MCF-7 cells
|
1.9 × 10−1 ± 6.0 × 10−2 µM
|
AlamarBlue® fluorescence intensity measurement
|
Download PDF
|
|
cultured MCF-7 cells
|
8.0 × 10−2 ± 5.8 × 10−3 µM
|
AlamarBlue® fluorescence intensity measurement
|
Download PDF
|
|
MDA-MB-231 (NC)
|
16.18 nM
|
CCK-8 assay
|
PMC10847378
|
|
MDA-MB-231 (DNAJC12 OE)
|
82.95 nM
|
CCK-8 assay
|
PMC10847378
|
|
BT-474 (NC)
|
160.8 nM
|
CCK-8 assay
|
PMC10847378
|
|
BT-474 (DNAJC12 siRNA)
|
31 nM
|
CCK-8 assay
|
PMC10847378
|
|
SK-BR-3 (NC)
|
66.45 nM
|
CCK-8 assay
|
PMC10847378
|
|
SK-BR-3 (DNAJC12 siRNA)
|
15.57 nM
|
CCK-8 assay
|
PMC10847378
|
|
MCF-7 (NC)
|
2672 nM
|
CCK-8 assay
|
PMC10847378
|
|
MCF-7 (DNAJC12 siRNA)
|
893.1 nM
|
CCK-8 assay
|
PMC10847378
|
|
GL261
|
1 µM
|
MTT assay
|
Download PDF
|
|
CT26 cells
|
325 nM (Dox solution), 84 nM (SNALPs siNeg-Dox)
|
MTT assay
|
Download PDF
|
|
B16BL6
|
0.273 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
BLM
|
0.904 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
BFS-1
|
2.437 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
B16BL6
|
0.086 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
BLM
|
0.217 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
BFS-1
|
0.597 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
SMMC-7721
|
2.965 μg/mL
|
MTT assay
|
Download PDF
|
|
A375
|
37.62 µM
|
CCK-8 colorimetric assay
|
Download PDF
|
|
SKOV3 cells
|
1.187 μM (for MiV-Dox)
|
MTT assay
|
Download PDF
|
|
4T1 cells
|
pH 7.4: 7.2 µg/mL; pH 6.5: 2.0 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
A549 cells
|
pH 7.4: 0.3 µg/mL; pH 6.5: 0.2 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
B16 cells
|
pH 7.4: 4.8 µg/mL; pH 6.5: 1.1 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
4T1 cells
|
3.045 µg/mL
|
MTT assay
|
Download PDF
|
|
HeLa cells
|
1.33 mg l-1
|
3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
|
Download PDF
|
|
Dox-resistant HeLa cells
|
2.46 mg l-1
|
3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
|
Download PDF
|
|
U87 MG cells
|
1.034 μg/ml
|
cytotoxicity assay (implied MTT assay)
|
Download PDF
|
|
HL-1 cells
|
2 µM
|
MUSE cell analyzer
|
PMC9481943
|
|
CFPAC-1
|
~0.5 µg/ml
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
PANC-1
|
~1.5 µg/ml
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
CAPAN-1
|
~0.2 µg/ml
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
PANC-198
|
~0.8 µg/ml
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
K562
|
0.32 μM
|
CellTiter-Blue viability assay
|
PMC7334570
|
|
Primary human AML blasts (AML patient 1)
|
0.63 μM
|
CellTiter-Blue viability assay
|
PMC7334570
|
|
Primary human AML blasts (AML patient 2)
|
0.63 μM
|
CellTiter-Blue viability assay
|
PMC7334570
|
|
McA- RH7777
|
2.207 mg/mL
|
MTS assay, non-linear regression
|
PMC9717415
|
|
C6 cells
|
6.59 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
C6 cells
|
4.36 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
A375 cells
|
30.40 μg/mL
|
MTT assays
|
Download PDF
|
|
4T1 cells
|
3.71 μg mL−1
|
CCK-8 assay
|
Download PDF
|
|
4T1 cells
|
0.99 μg mL−1
|
CCK-8 assay
|
Download PDF
|
|
NCI-H1299 cells
|
2.50 μg/mL
|
MTT assay
|
Download PDF
|
|
B16-F10 cells
|
0.341 µg mL−1
|
MTT assay
|
Download PDF
|
|
HEC-1A
|
0.778 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
Ishikawa
|
0.315 µM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
SKOV3
|
0.05 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
HFF
|
>10 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
SKOV3:HFF
|
0.1 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
SKOV3:HFF Spheroids
|
0.3 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
SKOV3:HFF Microspheres
|
0.3 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
SKOV3:HFF Assembled Spheroid Constructs
|
0.5 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
SKOV3:HFF Assembled Microsphere Constructs
|
2.5 x 10^-6 M
|
alamarBlue assay; log(inhibitor) dose–response curves
|
PMC11468982
|
|
BT474
|
0.080 ± 0.003 μM
|
ATPlite Luminescence ATP Detection Assay System, nonlinear regression model
|
Download PDF
|
|
SKBR3
|
0.034 ± 0.026 μM
|
ATPlite Luminescence ATP Detection Assay System, nonlinear regression model
|
Download PDF
|
|
SKOV3
|
0.092 ± 0.004 μM
|
ATPlite Luminescence ATP Detection Assay System, nonlinear regression model
|
Download PDF
|
|
MDA-MB-231
|
0.287 ± 0.002 μM
|
ATPlite Luminescence ATP Detection Assay System, nonlinear regression model
|
Download PDF
|
|
MDA-MB-231
|
0.51 µM
|
luminescent viability assay
|
PMC13005684
|
|
BE(2)-C
|
0.44 ± 0.01 μM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
SK-N-DZ
|
51.87 ± 1.95 nM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
Neonatal mouse cardiomyocytes
|
~2 μM
|
CCK-8 assay
|
Download PDF
|
|
MCF-7
|
0.094 μM
|
alamarBlue assay, calculated using GraphPad Prism 8.0 software
|
Download PDF
|
|
MCF-7
|
>10 μM
|
alamarBlue assay, calculated using GraphPad Prism 8.0 software
|
Download PDF
|
|
MCF-7
|
7.032 μM
|
alamarBlue assay, calculated using GraphPad Prism 8.0 software
|
Download PDF
|
|
MDA-MB-231 cells
|
14.4 µg/mL
|
MTT assay
|
Download PDF
|
|
HEK293 cells
|
0.02 µg/mL
|
MTT assay
|
Download PDF
|
|
HT-29 cells
|
8.86 ± 1.78 µg/ml (24h), 6.83 ± 1.06 µg/ml (48h), 4.89 ± 1.0
|
MTT assay
|
Download PDF
|
|
CHO cells
|
14.00 ± 1.07 µg/ml (24h), 9.63 ± 1.08 µg/ml (48h), 5.66 ± 1.
|
MTT assay
|
Download PDF
|
|
SU-DHL-2 cells
|
2.0 μmol/l
|
CCK-8 assay
|
Download PDF
|
|
HepG2 cells
|
10.7 ± 1.14 μM (24h), 3.51 ± 0.41 μM (48h)
|
CCK-8 assay
|
Download PDF
|
|
4T1
|
0.71 μg/mL
|
CCK-8 assay
|
Download PDF
|
|
4T1 cells
|
1.63 μg mL−1
|
CCK-8 assays
|
Download PDF
|
|
A549 cells
|
2.2 ± 0.4 μM
|
CCK-8 cytotoxicity assay
|
PMC11363298
|
|
MCF-7 cells
|
8.5 ± 2.9 μM
|
CCK-8 cytotoxicity assay
|
PMC11363298
|
|
MCF-7
|
7.278 lmol/L
|
CCK-8 assay
|
PMC12828152
|
|
MCF-7/ADR
|
27.96 lmol/L
|
CCK-8 assay
|
PMC12828152
|
|
MCF-7/ADR
|
142.28 lmol/L (24h), 33.31 lmol/L (48h), 11.18 lmol/L (72h)
|
CCK-8 assay
|
PMC12828152
|
|
4T1 cells
|
2.6 µg/mL
|
MTT assay
|
PMC11804646
|
|
HL-1
|
< 10 µM
|
Modified MTT method (MTS assay)
|
Download PDF
|
|
RAW 264.7
|
50 nM
|
Crystal Violet Cell Proliferation assay
|
PMC4265747
|
|
HepG2
|
1.13 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-M
|
1.19 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-GAL1
|
1.97 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-shScr
|
1.33 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-shGAL1
|
0.84 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2
|
0.86 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-M
|
0.81 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-GAL1
|
1.31 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-shScr
|
0.97 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
HepG2-shGAL1
|
0.44 µM
|
MTT assay, dose-response curves by non-linear regression
|
Download PDF
|
|
C26
|
0.44 μg/mL
|
MTT assay
|
PMC4876626
|
|
HepG2 cells
|
3.8 μg mL-1
|
MTT assay
|
PMC4876629
|
|
B16
|
1.5 µM
|
Sulforhodamine B (SRB) assay, absorbance measured at 590 nm
|
PMC4955068
|
|
B16
|
1.5 µM
|
Sulforhodamine B (SRB) assay, absorbance measured at 590 nm
|
PMC4955068
|
|
BFS-1
|
1.5 µM
|
Sulforhodamine B (SRB) assay, absorbance measured at 590 nm
|
PMC4955068
|
|
BFS-1
|
1.5 µM
|
Sulforhodamine B (SRB) assay, absorbance measured at 590 nm
|
PMC4955068
|
|
OSRC-2
|
1.2 µM
|
MTS method, spectrophotometer, dose-response curves fitted using SPSS software
|
Download PDF
|
|
786-O
|
1.5 µM
|
MTS method, spectrophotometer, dose-response curves fitted using SPSS software
|
Download PDF
|
|
H22 cells
|
0.29 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
4T1 cells
|
0.35 µg/mL
|
CCK-8 assay
|
Download PDF
|
|
TC-1
|
400 ng/mL
|
MTS assay
|
Download PDF
|
|
MC-38
|
200 ng/mL
|
MTS assay
|
Download PDF
|
|
PANC02
|
0.85 µM
|
Tumor cell growth inhibition assay
|
PMC5436521
|
|
MCF-7
|
310.35 ng/mL
|
MTT assay
|
PMC5327360
|
|
LNCaP
|
4.89 μg/mL
|
Cell viability assay
|
PMC5436523
|
|
H22
|
11.22 μg/mL
|
Cell viability assay
|
PMC5436523
|
|
A549
|
2.85 μg/mL
|
Cell viability assay
|
PMC5436523
|
|
NIH3T3
|
4.25 μg/mL
|
Cell viability assay
|
PMC5436523
|
|
1321 N1
|
1.1 µM
|
MTS assay
|
Download PDF
|
|
MDA-MB-231
|
1.4 µM
|
MTS assay
|
Download PDF
|
|
B16/ADR cells
|
27.89 μM
|
CCK-8 assay, non-linear curve fitting based on a logistic model
|
PMC12240195
|
|
HepG2 cells
|
1.6 μg mL−1
|
MTT assay
|
PMC5327644
|
|
H22 cells
|
0.74 μg mL−1
|
MTT assay
|
PMC5327644
|
|
MCF-7
|
0.14 μM
|
BrdU cell proliferation enzyme-linked immunosorbent assay (ELISA)
|
Download PDF
|
|
MDA-MB-231
|
0.25 μM
|
BrdU cell proliferation enzyme-linked immunosorbent assay (ELISA)
|
Download PDF
|
|
A549
|
0.23 μM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
HCT 116
|
1.8 μM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
Kasumi-1
|
1.39 ± 0.24 μmol/L
|
CCK-8 assay
|
Download PDF
|
|
HL-60/ADM
|
1.79 ± 0.13 μmol/L
|
CCK-8 assay
|
Download PDF
|
|
MDA-157
|
0.12 ± 0.01 µM
|
cell growth inhibition assays; automated cell counter (TC20, [Vendor]); software (Prism, GraphPad)
|
PMC7502856
|
|
MDA-231
|
0.11 ± 0.01 µM
|
cell growth inhibition assays; automated cell counter (TC20, [Vendor]); software (Prism, GraphPad)
|
PMC7502856
|
|
MDA-468
|
0.10 ± 0.01 µM
|
cell growth inhibition assays; automated cell counter (TC20, [Vendor]); software (Prism, GraphPad)
|
PMC7502856
|
|
HCC1806
|
0.10 ± 0.01 µM
|
cell growth inhibition assays; automated cell counter (TC20, [Vendor]); software (Prism, GraphPad)
|
PMC7502856
|
|
HEK293T
|
0.18 μM
|
CCK-8 kit, absorbance measured at 450 nm
|
Download PDF
|
|
HeLa
|
0.92 μM
|
CCK-8 kit, absorbance measured at 450 nm
|
Download PDF
|
|
MCF-7FR− cells (free Doxo)
|
99.8 nM
|
MTT assay
|
Download PDF
|
|
KBFR+ cells (free Doxo)
|
117.3 nM
|
MTT assay
|
Download PDF
|
|
4T1 cells
|
3.9 μM
|
CCK-8 assay
|
Download PDF
|
|
H9C2 cells
|
1.1 μM
|
CCK-8 assay
|
Download PDF
|
|
HepG2
|
35.88 ± 1.67 µg/ml
|
Wst -1 assay
|
PMC12459191
|
|
3D-HepG2 monoculture spheroids
|
179.4 µg/ml
|
Wst -1 assay
|
PMC12459191
|
|
3D-HepG2 coculture spheroids
|
179.4 µg/ml
|
Wst -1 assay
|
PMC12459191
|
|
BCSC-enriched 4T1 mammosphere cells
|
8.01 μg/mL
|
CCK-8 assay
|
Download PDF
|
|
MCF-7
|
0.19 μM
|
MTT assay
|
PMC5996354
|
|
iPSC-CM
|
4.3 μM
|
TetraZ-based dye assay
|
PMC6010982
|
|
RUES2-CM
|
58.2 μM
|
TetraZ-based dye assay
|
PMC6010982
|
|
3T3
|
7.1 × 10-2 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
3T3-MDR1
|
6.2 × 10-1 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
OVCAR8
|
4.1 × 10-1 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
NCI-ADRRes
|
4.5 × 101 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
KB-3-1
|
2.0 × 10-1 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
KB-8-5-11
|
1.0 × 101 µg/mL
|
Alamar Blue assay, CompuSyn software
|
PMC6299702
|
|
HeLa
|
1.11 μM
|
CCK-8 solution, OD 490 read by [Vendor] Scientific Microplate Reader.
|
PMC5771094
|
|
HepG2
|
0.84 μM
|
CCK-8 solution, OD 490 read by [Vendor] Scientific Microplate Reader.
|
PMC5771094
|
|
4T-1
|
1.28 μM
|
CCK-8 solution, OD 490 read by [Vendor] Scientific Microplate Reader.
|
PMC5771094
|
|
NIH 3T3
|
1.74 μM
|
CCK-8 solution, OD 490 read by [Vendor] Scientific Microplate Reader.
|
PMC5771094
|
|
HUVECs
|
3.28 ± 0.98 µg/mL
|
Standard MTT method
|
PMC5957002
|
|
MDA-MB-231
|
2.62 ± 0.45 µg/mL (for RGD-NPVs@MNPs/DOX), 11.31 ± 0.68 µg/m
|
Standard MTT method
|
PMC5957002
|
|
MDA-MB-231/ADR
|
3.95 ± 0.69 µg/mL (for RGD-NPVs@MNPs/DOX), 161.3 ± 9.98 µg/m
|
Standard MTT method
|
PMC5957002
|
|
4T1 cells
|
3.01 µg/mL
|
Cell Counting Kit-8 (CCK-8) assay from dose-response curves.
|
PMC5858512
|
|
MDA-MB-231
|
1.306 µM
|
CellTiter-Glo® assay; Dose response curve and IC50 calculation generated in GraphPad Prism software
|
Download PDF
|
|
MDA-MB-231
|
3.556 µM
|
CellTiter-Glo® assay; Dose response curve and IC50 calculation generated in GraphPad Prism software
|
Download PDF
|
|
MDA-MB-231
|
1.942 µM
|
CellTiter-Glo® assay; Dose response curve and IC50 calculation generated in GraphPad Prism software
|
Download PDF
|
|
MDA-MB-231
|
5.492 µM
|
CellTiter-Glo® assay; Dose response curve and IC50 calculation generated in GraphPad Prism software
|
Download PDF
|
|
MCF-7 cells
|
2.42 μg/mL
|
MTT assay
|
PMC5858167
|
|
MDA-MB-231 cells
|
0.57 ± 0.03 μg/mL
|
MTT assay
|
PMC9700474
|
|
MCF7 cells
|
0.59 ± 0.14 μg/mL
|
MTT assay
|
PMC9700474
|
|
A549 cells
|
0.5 μg/mL
|
MTT assay
|
PMC3936292
|
|
CAL27 cells
|
3.7 μM
|
CCK-8 assay
|
PMC9553242
|
|
4T1 cells
|
0.96 μg/mL
|
CCK-8 assay
|
PMC9508944
|
|
MG63 cells
|
0.178 μg mL−1
|
Cell Counting Kit-8 assay (CCK-8)
|
PMC9359454
|
|
HOS cells
|
0.294 μg mL−1
|
Cell Counting Kit-8 assay (CCK-8)
|
PMC9359454
|
|
143B cells
|
0.315 μg mL−1
|
Cell Counting Kit-8 assay (CCK-8)
|
PMC9359454
|
|
H9C2 cells
|
0.149 μg mL−1
|
Cell Counting Kit-8 assay (CCK-8)
|
PMC9359454
|
|
MG63 cells
|
9.94 μg mL−1
|
CCK-8 assay, calculated using Graphpad prism 6.0
|
PMC9359454
|
|
H9C2 cells
|
5.09 μg mL−1
|
CCK-8 assay, calculated using Graphpad prism 6.0
|
PMC9359454
|
|
4T1
|
0.05 µM
|
Cell survival/selection
|
Download PDF
|
|
4T1 cells
|
3.8 ± 0.09 µg/mL
|
CCK8 assay
|
PMC9273187
|
|
HeLa cells
|
~0.01 μM
|
WST-1 assay
|
PMC5043431
|
|
UM-SCC-22B
|
0.588±0.099 mg/L
|
MTT assay
|
PMC3590588
|
|
22B-pcFluc-DEVD
|
0.624±0.126 mg/L
|
MTT assay
|
PMC3590588
|
|
A549
|
0.44 µM
|
Alamar Blue Cell Viability Reagent
|
PMC12538875
|
|
A549-DoxR
|
1.66 µM
|
Alamar Blue Cell Viability Reagent
|
PMC12538875
|
|
HT29
|
0.8 μM
|
Neutral red staining assay
|
Download PDF
|
|
HT29/MDR
|
12.5 μM
|
Neutral red staining assay
|
Download PDF
|
|
LoVo
|
1.5 μM
|
CCK-8 assay
|
Download PDF
|
|
HCT8
|
1.5 μM
|
CCK-8 assay
|
Download PDF
|
|
LoVo/ADR
|
12 μM
|
CCK-8 assay
|
Download PDF
|
|
HCT8/ADR
|
10 μM
|
CCK-8 assay
|
Download PDF
|
|
SaOS-2
|
61.4 µM
|
MTT assay
|
PMC12272969
|
|
U2OS
|
58.5 µM
|
MTT assay
|
PMC12272969
|
|
SaOS-2-Re
|
122.9 µM
|
MTT assay
|
PMC12272969
|
|
U2OS-Re
|
118.6 µM
|
MTT assay
|
PMC12272969
|
|
A549
|
0.056 mM
|
cell viability assays
|
PMC12422130
|
|
K562
|
0.056 mM
|
cell viability assays
|
PMC12422130
|
|
K562r
|
1.54 mM
|
cell viability assays
|
PMC12422130
|
|
SNU449
|
218 ± 38 µM
|
resazurin reduction assay
|
Download PDF
|
|
SNU449
|
32.9 ± 31 µM
|
resazurin reduction assay
|
Download PDF
|
|
SNU449
|
12.2 ± 11 µM
|
resazurin reduction assay
|
Download PDF
|
|
Huh-7
|
22.8 ± 10 µM
|
resazurin reduction assay
|
Download PDF
|
|
Huh-7
|
5.06 ± 1.5 µM
|
resazurin reduction assay
|
Download PDF
|
|
Huh-7
|
0.943 ± 0.78 µM
|
resazurin reduction assay
|
Download PDF
|
|
HepG2
|
11.1 ± 6.4 µM
|
resazurin reduction assay
|
Download PDF
|
|
HepG2
|
0.584 ± 0.11 µM
|
resazurin reduction assay
|
Download PDF
|
|
HepG2
|
0.478 ± 0.031 µM
|
resazurin reduction assay
|
Download PDF
|
|
MCF7
|
13.5 ± 14 µM
|
resazurin reduction assay
|
Download PDF
|
|
MCF7
|
0.547 ± 0.22 µM
|
resazurin reduction assay
|
Download PDF
|
|
MCF7
|
0.267 ± 0.11 µM
|
resazurin reduction assay
|
Download PDF
|
|
MCF-7
|
4.28 µg/ml
|
CCK-8
|
PMC11290069
|
|
MCF-7/ADR
|
51.37 µg/ml
|
CCK-8
|
PMC11290069
|
|
Ishikawa
|
1.016 µM
|
CCK-8 assay
|
PMC13104261
|
|
RL-95-2
|
2.003 µM
|
CCK-8 assay
|
PMC13104261
|
|
A549
|
0.088 μg/mL
|
MTT assay
|
PMC8647655
|
|
MCF-7
|
0.043 μg/mL
|
MTT assay
|
PMC8647655
|
|
MCF-7/ADR
|
61.55 μg/mL
|
MTT assay
|
PMC8647655
|
|
5637 cells
|
2.8 ± 0.6 μM
|
MTT assay
|
PMC8627283
|
|
A549 cells
|
3.0 ± 0.5 μM
|
MTT assay
|
PMC8627283
|
|
5637 cells
|
3.2 ± 0.4 μM
|
MTT assay
|
PMC8627283
|
|
MDA-MB-435S
|
27.85 μg/mL
|
MTT assay
|
PMC8121622
|
|
MCF-7 cells
|
5.25 μmol/L
|
MTT assay
|
PMC8528549
|
|
MDA-MB-231
|
1 µmol L−1
|
MTT assay
|
PMC7935351
|
|
BN175
|
26.1 ± 8.3 µM
|
Sulforhodamine B (SRB) assay
|
PMC8214027
|
|
BN175
|
19.3 ± 9.4 µM
|
Sulforhodamine B (SRB) assay
|
PMC8214027
|
|
HUVECs
|
9.7 ± 0.4 µM
|
Sulforhodamine B (SRB) assay
|
PMC8214027
|
|
HUVECs
|
10.1 ± 2.6 µM
|
Sulforhodamine B (SRB) assay
|
PMC8214027
|
|
A549 (Doxorubicin TIS)
|
3.25 μmol/L
|
alamarBlue™ assay
|
Download PDF
|
|
vero monkey kidney cells
|
2.59 µg/mL
|
MTT cell viability assay
|
PMC7591100
|
|
HepG2
|
1.42±0.02 μM
|
CCK-8 assay
|
PMC8379713
|
|
HCC-LM3
|
6.60±1.06 μM
|
CCK-8 assay
|
PMC8379713
|
|
143B adherent cells
|
4.26 µM
|
IncuCyte growth rate assessment
|
Download PDF
|
|
143B WNT5BKO adherent cells
|
6.03 µM
|
IncuCyte growth rate assessment
|
Download PDF
|
|
143B spheres
|
39810.72 µM
|
IncuCyte growth rate assessment
|
Download PDF
|
|
143B WNT5BKO spheres
|
5011.87 µM
|
IncuCyte growth rate assessment
|
Download PDF
|
|
CL1-0
|
3.03 ± 0.445 μM
|
NAS biochip, CCK-8 assay, cell staining method
|
Download PDF
|
|
MCF-7
|
1.5 ± 0.124 μM
|
NAS biochip, cell staining method
|
Download PDF
|
|
Py8119 cells
|
1.02 µM
|
MTT assay
|
Download PDF
|
|
HepG2 cells
|
94.64 mM
|
Cell viability assay
|
Download PDF
|
|
HepG2 cells
|
41.24 mM
|
Cell viability assay
|
Download PDF
|
|
P388 parental cells
|
0.01 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
P388 DOX-treated cells
|
1.6 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
P388 DOX+CEL-treated cells
|
0.03 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
CLBL-1 parental cells
|
0.44 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
CLBL-1 DOX-treated cells
|
1.99 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
CLBL-1 DOX+CEL-treated cells
|
0.24 µM
|
PrestoBlue® assay, spectrophotometrically using an EnSpire microplate reader
|
Download PDF
|
|
KB cells
|
0.0896
|
CCK-8 assay
|
PMC10069508
|
|
4T1 cells
|
5.438 μg/mL
|
MTT assay
|
PMC10046155
|
|
A549
|
26.993 μg/mL
|
Cell Counting Kit-8 (CCK8) assay
|
PMC9960730
|
|
A549/ADM
|
130.626 μg/mL
|
Cell Counting Kit-8 (CCK8) assay
|
PMC9960730
|
|
MDA-MB-231
|
0.91 µg/mL
|
MTT method
|
PMC9926996
|
|
4T1
|
1.62 µg/mL
|
MTT method
|
PMC9926996
|
|
MDA-MB-231
|
0.27 µg/mL
|
MTT method
|
PMC9926996
|
|
4T1
|
0.46 µg/mL
|
MTT method
|
PMC9926996
|
|
NCH551b
|
361.3 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
NCH1681
|
196.0 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
NCH612
|
202.1 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
NCH645
|
152.4 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
NCH3763
|
167.7 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
NCH620
|
120.6 nM
|
CellTiter-Glo®3D Cell Viability Assay
|
Download PDF
|
|
MDA-MB-231 cells
|
7.258 μg/mL
|
MTT assay
|
PMC10040171
|
|
MDA-MB-231 cells
|
3.785 μg/mL
|
MTT assay
|
PMC10040171
|
|
4T1 cells
|
32.04 μg/mL
|
MTT assay
|
PMC10040171
|
|
4T1 cells
|
9.849 μg/mL
|
MTT assay
|
PMC10040171
|
|
K7M2
|
3.59 µM
|
MTT test
|
Download PDF
|
|
Mz-ChA-1
|
27.8 µM (24 h); 3.8 µM (72 h); 19.8 µM (2 h); 11.6 µM (2 h d
|
MTT assay
|
Download PDF
|
|
H69
|
13.6 µM (24 h); 4.0 µM (72 h); 81.8 µM (2 h); 54.4 µM (2 h d
|
MTT assay
|
Download PDF
|
|
PC3
|
48.4 µM
|
MTT assay (implied)
|
Download PDF
|
|
MDA-MB-231 breast cells
|
~ 5 μg/mL
|
typical methyl thiazolyl tetrazolium (MTT) assay
|
Download PDF
|
|
MDA-MB-231
|
393.3 ng/mL
|
resazurin assay
|
Download PDF
|
|
SK-OV-3
|
323.0 ng/mL
|
resazurin assay
|
Download PDF
|
|
MDA-MB-231
|
5.0 ng/mL
|
resazurin assay
|
Download PDF
|
|
SK-OV-3
|
11.0 ng/mL
|
resazurin assay
|
Download PDF
|
|
MCF-7
|
1.05 ± 0.01 µg/mL
|
MTT assay
|
Download PDF
|
|
CSLCs
|
28.33 ± 0.66 µg/mL
|
MTT assay
|
Download PDF
|
|
SKOV3 cells
|
1.38 µM
|
MTT assay
|
Download PDF
|
|
SKOV3
|
1.38 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
7.92 µM
|
MTT assay
|
Download PDF
|
|
Ishikawa
|
8.16 µM
|
MTT assay
|
Download PDF
|
|
DU145
|
1.5 µM
|
MTT assay
|
Download PDF
|
|
CAKI-1
|
9.67 µM
|
MTT assay
|
Download PDF
|
|
OVCAR3
|
6.96 µM
|
MTT assay
|
Download PDF
|
|
HK-2
|
7.45 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
13.5 μg/mL
|
CCK-8 kit, microplate reader, sigmoidal regressions
|
Download PDF
|
|
MDA-MB-231 cells
|
0.86 µg/mL
|
MTT assay
|
PMC13006383
|
|
MCF7 cells
|
1.27 µg/mL
|
MTT assay
|
PMC13006383
|
|
4T1 cells
|
2.28 ± 0.4 μg/mL
|
MTT method
|
PMC12728424
|
|
U87 cells
|
1.070 μg/mL
|
CCK-8 assay
|
PMC13110662
|
|
MCF-7 cells
|
2.91 µM
|
CCK-8 assay
|
PMC12147814
|
|
H9C2 cells
|
1.58 μM
|
CCK-8 assay
|
PMC12302406
|
|
CT26
|
5.66 ± 0.08 µg/mL
|
Cell Counting Kit-8 (CCK-8) method
|
PMC11972606
|
|
4T1
|
17.14 ± 1.39 µg/mL
|
Cell Counting Kit-8 (CCK-8) method
|
PMC11972606
|
|
BxPC-3 cells
|
3.67 μg/mL
|
MTT assay
|
PMC11693971
|
|
HCT-116 cells
|
10.5 ±0.41 µg/mL
|
MTT assay
|
PMC11700881
|
|
SCC-15
|
4.489 μg/mL
|
CCK-8 kit assay
|
PMC11545731
|
|
ZR75.1
|
14.8 μg/mL
|
CCK-8 assay
|
PMC11317049
|
|
CM/MCF-7 cells
|
0.659 μg/mL
|
MTT assay
|
PMC11162247
|
|
Caco-2
|
0.74 µg/mL
|
MTT assay, non-linear regression analysis using GraphPad Prism software
|
PMC11070442
|
|
MCF-7
|
1.725 µg/mL
|
MTT assay, non-linear regression analysis using GraphPad Prism software
|
PMC11070442
|
|
Y79 cells
|
6.68 ± 0.03 μg/mL
|
CCK-8 assay
|
PMC11297587
|
|
MCF-7
|
46.44 µg/mL
|
MTT assay, Graphpad Prism Statistics software
|
PMC11378800
|
|
MCF-7
|
43.68 µg/mL
|
MTT assay, Graphpad Prism Statistics software
|
PMC11378800
|
|
MCF-7/ADR
|
66.12 µg/mL
|
MTT assay, Graphpad Prism Statistics software
|
PMC11378800
|
|
MCF-7/ADR
|
44.57 µg/mL
|
MTT assay, Graphpad Prism Statistics software
|
PMC11378800
|
|
AC16
|
12.56 μM
|
MTT test
|
PMC11180469
|
|
U87MG
|
0.89 μM
|
MTT test
|
PMC11180469
|
|
HCT116
|
261.2 nM
|
CCK-8 assay
|
PMC10777867
|
|
4-T1 cells
|
1.76 μg/mL
|
CCK-8 assay
|
PMC10800289
|
